UPDATE
: Monday, September 7, 2020
Home
Login
Mobile Version
All
Hospital
Pharma
Bio
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
Special Series in Celebration of KBR’s 4th Anniversary
ASCO 2020 Highlights
Opinion
Reporter’s Notebook
Search
트위터
페이스북
RSS
상단여백
제목보기
제목보기
제목+내용
'Mucosa healing essential for treating inflammatory bowel disease'
by Lee Han-soo
2019-08-30 12:42
CAR-T therapy Kymriah, pie in the sky for Korean patients
by Kim Yun-mi
2019-08-29 14:35
Ildong’s subsidiary secures 1st anticancer drug pipeline
by Lee Han-soo
2019-08-29 13:37
Prosecutors raid Sillajen over alleged use of undisclosed information
by Lee Han-soo
2019-08-29 11:27
Antidiabetic DPP-4 inhibitors mark double-digit sales growth
by Jeong Sae-im
2019-08-29 11:24
라인
Crystal Genomics' immunotherapy gets orphan drug status from US regulator
by Lee Han-soo
2019-08-28 17:44
FDA OKs Boryung's P1 trial for immunotherapy candidate
by Lee Han-soo
2019-08-28 14:21
Sales of new gastric acid blocker K-Cab top ₩10 billion
by Jeong Sae-im
2019-08-28 13:26
Leo Pharma submits IND application for JW Pharmaceutical’s atopy treatment
by Lee Han-soo
2019-08-28 13:24
Pharmacists demand audit over Gliatilin’s insurance benefit
by Song Soo-youn
2019-08-27 16:01
라인
HLB to test rivoceranib+Lonsurf in colon cancer
by Jeong Sae-im
2019-08-27 15:39
Pharmaceutical sector’s job growth twice of all industries’ average
by Jeong Sae-im
2019-08-26 11:39
Invossa still effective despite mislabeling, maker claims
by Lee Han-soo
2019-08-23 20:16
Vivozon finishes P3 trial for nonnarcotic analgesics
by Lee Han-soo
2019-08-23 16:03
HLB wins FDA nod for P2 trial on rivoceranib in adenoid cystic carcinoma
by Jeong Sae-im
2019-08-23 15:02
라인
Ministry OKs P1 trial into Haim Bio’s metabolism anticancer drug
by Lee Han-soo
2019-08-23 13:53
'Peptron's Parkinson's disease treatment blocks levodopa side effects'
by Lee Han-soo
2019-08-22 17:53
‘Drug firm’s pick of doctor to attend conference overseas illegal’
by Kim Yun-mi
2019-08-22 15:45
SK Biopharmaceutical’s sleepiness drug initially aimed to treat depression
by Lee Hye-seon
2019-08-22 15:37
Tego Science’s diabetic foot ulcer treatment gets insurance benefit
by Lee Han-soo
2019-08-22 15:34
-
이전
31
32
33
34
35
36
37
38
-
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
여백
Most viewed
1
‘Cyramza helped improve gastric cancer treatment in Korea’
2
‘Reduced-dose prasugrel effective for ACS patients undergoing PCI’
3
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
4
SNUBH develops AI model predicting patients at risk of cerebral aneurysm
5
Novavax releases encouraging phase-1 results on Covid-19 vaccine candidate
6
LG Chem, SK Bioscience end sales partnership with Daewoong
7
UBcare wins patent for tech to monitor suspected infectious diseases
8
176 civic groups furious over government-doctors deal
9
Recovered Covid-19 patients suffer from aftereffects – for long
10
Regulator OKs JW Pharma's rheumarthritis drug for treating giant cell arteries
여백
Opinion
[Column] Correct diagnosis leads to proper treatment
[Column] How ongoing doctors’ strike is different from 20 years ago
A Korean-American Doctor asks: Is Korea truly in 2020?
여백
Back to Top